tbuckley/cabot-search huggingface dataset:
LBA76 Overall survival (OS) results from the phase III TROPiCS-02 study of sacituzumab govitecan (SG) vs treatment of physician's choice (TPC) in patients (pts) with HR+/HER2- metastatic breast cancer (mBC)
Authors: H.S. Rugo, A. Bardia, F. Marmé, J. Cortés, P. Schmid, D. Loirat, O. Tredan, E.M. Ciruelos, F. Dalenc, P. Gomez Pardo, K. Jhaveri, R.J. Delaney, T. Valdez, H. Wang, W. Verret, S.M. Tolaney
Journal: Annals of Oncology (2022)
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
Authors: Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, Antje Blank, Natalia Voronkova, Tatiana Stepanova, Olga Sagalova, Vladimir Chulanov, Marina Osipenko, Viacheslav Morozov, Natalia Geyvandova, Snezhana Sleptsova, Igor G Bakulin, Ilsiyar Khaertynova, Marina Rusanova, Anita Pathil, Uta Merle, Birgit Bremer, Lena Allweiss, Florian A Lempp, Kerstin Port, Mathias Haag, Matthias Schwab, Julian Schulze zur Wiesch, Markus Cornberg, Walter E Haefeli, Maura Dandri, Alexander Alexandrov, Stephan Urban
Journal: The Lancet Infectious Diseases (2022)
Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study
Authors: Anne Sofie Schott Andersen, Stine Maarbjerg, Navid Noory, Tone Bruvik Heinskou, Julie Lyng Forman, Giorgio Cruccu, Messoud Ashina, Lars Bendtsen
Journal: The Lancet Neurology (2022)
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Authors: Alison C Tree, Peter Ostler, Hans van der Voet, William Chu, Andrew Loblaw, Daniel Ford, Shaun Tolan, Suneil Jain, Alexander Martin, John Staffurth, John Armstrong, Philip Camilleri, Kiran Kancherla, John Frew, Andrew Chan, Ian S Dayes, Aileen Duffton, Douglas H Brand, Daniel Henderson, Kirsty Morrison, Stephanie Brown, Julia Pugh, Stephanie Burnett, Muneeb Mahmud, Victoria Hinder, Olivia Naismith, Emma Hall, Nicholas van As, E Lartigau, S Patton, A Thompson, M Winkler, P Wells, T Lymberiou, D Saunders, M Vilarino-Varela, P Vavassis, T Tsakiridis, R Carlson, G Rodrigues, J Tanguay, S Iqbal, M Winkler, S Morgan, A Mihai, A Li, O Din, M Panades, R Wade, Y Rimmer, M Panades, N Oommen
Journal: The Lancet Oncology (2022)
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
Authors: Gabriel Figueroa-Parra, Emily L Gilbert, Maria O Valenzuela-Almada, Sebastian Vallejo, Matthew R Neville, Naomi J Patel, Claire Cook, Xiaoqing Fu, Ramla Hagi, Gregory C McDermott, Michael A Dilorio, Lucy Masto, Kathleen M M Vanni, Emily Kowalski, Grace Qian, Yuqing Zhang, Zachary S Wallace, Alí Duarte-García, Jeffrey A Sparks
Journal: The Lancet Rheumatology (2022)
Bacterial Contamination of Arterial Lines
Authors: Tamotsu Shinozaki
Journal: JAMA (1983)

One hundred seventeen patients had indwelling arterial lines for hemodynamic monitoring and blood sampling. The duration of catheterization varied from 25 to 439 hours, during which time no components of the system were replaced. In contrast to other reports, our study showed no instance of contamination of transducer dome fluid when the continuous flush device was located just distal to the transducer. The sampling stopcock showed bacterial growth in 16.2% of patients. In the one case in which the arterial catheter tip, stopcock, and patient's blood showed the same organism, culture of the transducer fluid was negative. Our results suggest that elimination of a static inline fluid column and proper aseptic sampling technique limit risk to the patient of transmitted bacterial infection from the fluid in the system. Routine changes of components of the system are not indicated and a substantial cost saving can be achieved. (<i>JAMA</i>1983;249:223-225)
TCT-220 Impact of Intravascular Ultrasound Use on 1-Year Outcomes After Infra-Popliteal Endovascular Intervention
Authors: Daniel Snyder, Robert Zilinyi, Danial Saleem, Isaac Dreyfus, Zachary Girvin, Samuel Bruce, Matthew Finn, Sanjum Sethi, Ajay Kirtane, Sahil Parikh
Journal: Journal of the American College of Cardiology (2022)
TCT-243 Effective Measures for Radiation Protection in the Cath Lab
Authors: Stergios Soulaidopoulos, George Latsios, Antonios Karanasos, Andreas Synetos, George Lazaris, Marianna Leopoulou, Sotiris Tsalamandris, Konstantinos Toutouzas, Konstantinos Tsioufis
Journal: Journal of the American College of Cardiology (2022)
TCT-236 Accuracy of the FFRCT Planner in Coronary Calcific Lesions
Authors: Marta Belmonte, Carlos Collet, Bjarne Norgaard, Hiromasa Otake, Brian Ko, Bon-Kwon Koo, Takuya Mizukami, Adam Updegrove, Emanuele Barbato, Bernard De Bruyne, Jonathon Leipsic, Charles Taylor, Michael Maeng, Jeroen Sonck
Journal: Journal of the American College of Cardiology (2022)
TCT-237 Clinical Effectiveness of Functional Assessment of Non-Culprit Coronary Lesions Using an Optical Coherence Tomography Computational Algorithm: A CLIMA Post-Hoc Analysis
Authors: Flavio Giuseppe Biccirè, Riccardo Di Pietro, Caterina Debelak, Alberto Boi, Christos Bourantas, Simone Budassi, Giuseppe Varricchione, Emanuele Sammartini, Francesco Versaci, Franco Fabbiocchi, Francesco Burzotta, Yukio Ozaki, Eloisa Arbustini, Fernando Alfonso, Francesco Prati
Journal: Journal of the American College of Cardiology (2022)
TCT-231 Correlation and Diagnostic Agreement of Quantitative Flow Ratio With Fractional Flow Reserve in Saphenous Vein Grafts
Authors: Ruben de Winter, Yvemarie Somsen, Pepijn van Diemen, Ruurt Jukema, Roel Hoek, Mathé Jonker, Albert van Rossum, Rolf Kooistra, Jasper Janssen, Sina Porouchani, Adriaan Wilgenhof, Ibrahim Danad, Niels Verouden, Johan Reiber, Alexander Nap, Paul Knaapen
Journal: Journal of the American College of Cardiology (2022)
TCT-216 Prediction of Overall Mortality in Patients Who Underwent Endovascular Treatment for Peripheral Artery Disease
Authors: Jung-Joon Cha, Young Hak Chung, Young-Guk Ko, Jae-Hwan Lee, Chang-Hwan Yoon, Cheol Woong Yu, Seung-Whan Lee, Sang-Rok Lee, Seung Hyuk Choiu, Yoon Seok Koh, Pil-Ki Min
Journal: Journal of the American College of Cardiology (2022)
TCT-221 Outcomes of Below the Knee Balloon-Only Percutaneous Transluminal Angioplasty: Data From the XLPAD Registry
Authors: David Fernandez Vazquez, Shirling Tsai, Yu-Lun Liu, Lawrence Hoang, Hua Lu, Zachary Rosol, Emmanouil Brilakis, Mehdi Shishehbor, Subhash Banerjee
Journal: Journal of the American College of Cardiology (2022)
TCT-246 Superior Radiation Protection for Operator and Assistant in Acute and Elective Coronary Procedures With a Ceiling-Suspended Protection System—Data From the OSCAR Registry
Authors: Mathias Brandt, Erika Prinz, Bernhard Strohmer, Michael Lichtenauer, Lukas Motloch, Olaf Nairz, Uta Hoppe
Journal: Journal of the American College of Cardiology (2022)
TCT-235 5-Year Prognostic Value of QFR-Guided Revascularization in Patients With Stable Coronary Artery Disease: A Multicenter Registry
Authors: Carlos Cortes, Pablo Fernández Corredoira, Fernando Rivero, Alfonso Freites Esteves, Octavio Jímenez Melo, Luis Goncalves-Ramírez, Lili Liu, Ainhoa Perez guerrero
Journal: Journal of the American College of Cardiology (2022)
TCT-238 Optical Flow Ratio From Co-Registration of Coronary Angiography and Optical Coherence Tomography for Predicting Stenting Result and Physiological Significance of Residual Disease
Authors: Daixin Ding, Shengxian Tu, Yingguang Li, Chunming Li, Wei Yu, Antonio Maria Leone, Cristina Aurigemma, Enrico Romagnoli, Rocco Vergallo, Carlo Trani, William Wijns, Francesco Burzotta
Journal: Journal of the American College of Cardiology (2022)
TCT-227 The Efficacy of Reperfusion Therapy Treating Acute Intermediate High-Risk Pulmonary Embolism Patients
Authors: Andrius Berukstis, Greta Burneikaite, Giedrius Davidavicius, Mindaugas Mataciunas, Giedrius Navickas, Rasa Kugiene, Andrius Aidietis, Taida Ivanauskiene
Journal: Journal of the American College of Cardiology (2022)
TCT-233 Investigation of the Utility of Angiography-Based Fractional Flow Reserve (FFRangio) in Comparison to Wire-Based Coronary Fractional Flow Reserve (FFR) in the Determination of Treatment Planning and Clinical Prognosis in Patients With Coronary Artery Disease—The PROVISION Study Protocol
Authors: Toru Tanigaki, Hitoshi Matsuo, Hiroyoshi Yokoi
Journal: Journal of the American College of Cardiology (2022)
TCT-240 Two Years Clinical Outcomes of FFRangio Guided Treatment for Coronary Artery Disease
Authors: Guy Witberg, Ilan Richter, Tamir Bental, Amos Levi, Hana Vaknin Assa, Toru Tanigaki, Masafumi Nakayama, Hiroyuki Omori, Ryosuke Itakura, Yoshiaki Kawase, Hitoshi Matsuo, Ran Kornowski
Journal: Journal of the American College of Cardiology (2022)
TCT-229 Percutaneous Thrombectomy in Patients With Pulmonary Embolism and Contraindications for Thrombolysis: A Systematic Review and Meta-Analysis
Authors: Ioannis Milioglou, Ioannis Farmakis, Mohannad Wazirali, Steven Ajluni, Tasveer Khawaja, George Giannakoulas, Mehdi Shishehbor, Jun Li
Journal: Journal of the American College of Cardiology (2022)
TCT-247 Superior Radiation Protection With a Ceiling-Suspended Protection System in Emergency PCI for Acute Myocardial Infarction—Data From the OSCAR Registry
Authors: Mathias Brandt, Erika Prinz, Matthias Hammerer, Bernhard Strohmer, Lukas Motloch, Olaf Nairz, Uta Hoppe
Journal: Journal of the American College of Cardiology (2022)
TCT-218 Influence of Target Lesion Locations on Clinical Outcomes After Endovascular Therapy in Patients With Peripheral Artery Disease
Authors: Pil-Ki Min, Young Hak Chung, Jung-Joon Cha, Young-Guk Ko, Donghoon Choi, Jae-Hwan Lee, Chang-Hwan Yoon, Cheol Woong Yu, Seung-Whan Lee, Sang-Rok Lee, Seung Hyuk Choiu, Yoon Seok Koh
Journal: Journal of the American College of Cardiology (2022)
TCT-228 Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension Previously Operated by Pulmonary Endarterectomy
Authors: Asger Andersen, Jacob Hansen, Michael Maeng, Soren Mellemkjær, Lars Ilkjær, Jens Erik Nielsen-Kudsk
Journal: Journal of the American College of Cardiology (2022)
TCT-224 MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: XTOSI Trial 24 Month Results
Authors: Jia Sheng Tay, Darius Aw, Edward Choke, Kalpana Vijaykumar, Shin Chuen Cheng
Journal: Journal of the American College of Cardiology (2022)
TCT-239 Prognostic Value of Optical Flow Ratio Measured Immediately After PCI in Patients With Acute Coronary Syndrome
Authors: Ming Zeng, Boling Yi, Qianhui Sun, Chen Zhao, Ziqian Weng, Yuhan Qin, Luping He, Yishuo Xu, Sining Hu, Shengxian Tu, Haibo Jia, Bo Yu
Journal: Journal of the American College of Cardiology (2022)
TCT-212 Twenty-Four Month Results in Patients With Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial
Authors: Michael Bloch, Ajay Kirtane, Felix Mahfoud, Michel Azizi, Jan Basile, Joost Daemen, Manish Saxena, Philippe Gosse, Kintur Sanghvi, Roland Schmieder
Journal: Journal of the American College of Cardiology (2022)
TCT-226 Management of Pulmonary Embolism With and Without Right Heart Failure
Authors: Aaqib Malik, Akshay Goel, Dhrubajyoti Bandyopadhyay, Rahul Gupta, Adrija Hajra, Suchith Shetty, Wilbert Aronow, Syed Abbas Haidry, Hasan Ahmad
Journal: Journal of the American College of Cardiology (2022)
TCT-250 A Novel Coronary Computed Tomography Angiography Deep-Learning Methodology for Coronary Atheroma Quantification and Characterization Trained Using Near-Infrared Spectroscopy-Intravascular Ultrasound
Authors: Anantharaman Ramasamy, Hessam Sokooti, Xiaotong Zhang, Evangelia Tzorovili, Retesh Bajaj, Pieter Kitslaar, Rajiv Amersey, Ajay Jain, Mick Ozkor, Johan Reiber, Jouke Dijkstra, Patrick Serruys, Ryo Torii, James Moon, Anthony Mathur, Andreas Baumbach, Francesca Pugliese, Christos Bourantas
Journal: Journal of the American College of Cardiology (2022)
TCT-257 FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 2-Year Results From the FFR REACT Trial
Authors: Joost Daemen, Tara Neleman, Frederik Groenland, Laurens Zandvoort, Jurgen Ligthart, Karen Witberg, Mattie Lenzen, Paul Cummins, Eric Boersma, Rutger Nuis, Wijnand Den Dekker, Roberto Diletti, Jeroen Wilschut, Felix Zijlstra, Nicolas Van Mieghem
Journal: Journal of the American College of Cardiology (2022)
TCT-252 Comparison of the Estimations of ElucidVivo Software and NIRS-IVUS for Lumen, Vessel Wall and Plaque Dimensions and Its Composition
Authors: Ramya Parasa, Anantharaman Ramasamy, Ryo Torii, Francesca Pugliese, Anthony Mathur, James Moon, Andreas Baumbach, Rajiv Amersey, Andrew Deaner, Andrew Buckler, Christos Bourantas
Journal: Journal of the American College of Cardiology (2022)
TCT-254 Histology-Trained Deep Learning Methodology for Automated Coronary Plaque Component Classification in Combined Intravascular Ultrasound-Optical Coherence Tomography Images
Authors: Retesh Bajaj, Xingru Huang, Natasha Alves, Jill Weyers, Molly Levine, Mohil Garg, Soe Maung, Kit Bransby, Ryo Torii, Rob Krams, Hector Garcia-Garcia, Anthony Mathur, Andreas Baumbach, Qianni Zhang, Brian Courtney, Christos Bourantas
Journal: Journal of the American College of Cardiology (2022)
TCT-258 Instantaneous Wave Free Ratio for the Assessment of Intermediate Left Main Coronary Artery Stenosis: Correlations With FFR/IVUS and Prognostic Implications: The iLITRO - EPIC07 Study
Authors: Tamara Garcia Camarero, Bruno Garcia-Del-Blanco, Marcelo Jiménez Kockar, Jesus Jimenez-Mazuecos, Francisco Fernandez Salinas, Josep Gomez Lara, Salvatore Brugaletta, Fernando Alfonso, Ricardo Palma Carbajal, Antonio Gomez Menchero, Raul Millan, David Tejada Ponce, Jose Antonio Linares Vicente, Soledad Ojeda, Eduardo Pinar Bermudez, Estefania Fernandez, Francisco J. Morales-Ponce, Eduardo Molina Navarro, Javier Escaned, Armando Perez de Prado, Oriol Rodriguez Leor
Journal: Journal of the American College of Cardiology (2022)
TCT-255 Clinical and Coronary Physiology Characteristics of Patients With Residual Angina After Percutaneous Coronary Intervention
Authors: Damien Collison, Samuel Copt, Takuya Mizukami, Matthaios Didagelos, Muhammad Aetesam-ur-Rahman, Peter McCartney, Carlos Collet, Tom Ford, Mitchell Lindsay, Paul Rocchiccioli, Richard Brogan, Stuart Watkins, Margaret McEntegart, Richard Good, Keith Robertson, Patrick O’Boyle, Andrew Davie, Adnan Khan, Stuart Hood, Hany Eteiba, Colin Berry, Keith Oldroyd
Journal: Journal of the American College of Cardiology (2022)
TCT-256 Diagnostic and Prognostic Characteristics of Microvascular Resistance Reserve: From the Multi-Center ILIAS Registry
Authors: Coen Boerhout, Guus De Waard, Bon-Kwon Koo, Joo Myung Lee, Javier Escaned, Tsunekazu Kakuta, Jan Piek, Tim Van de Hoef
Journal: Journal of the American College of Cardiology (2022)
TCT-522 Outcomes of Patients Undergoing ViV TAVR With the Current-Generation Transcatheter Aortic Valves for Purely Regurgitant Surgical Bioprostheses
Authors: Radoslaw Pracon, Michael McGarvey, Aleksandar Dimitrov, Suzane Cadiz, Tito Kabir, Miles Dalby, Alison Duncan, S.W. Davies, Vasileios Panoulas
Journal: Journal of the American College of Cardiology (2022)
TCT-45 Cholinesterase Inhibitors Reduce Mortality in Patients With Myocardial Infarction and Alzheimer´s disease
Authors: Kristina Haugaa, Henrik Zetterberg, Juliane Jurga, Dorota Religa, Maria Eriksdotter, Bahira Shahim, Hong Xu
Journal: Journal of the American College of Cardiology (2022)
TCT-305 The Effect of Diltiazem Versus Placebo on Microvascular Dysfunction Assessed by Serial Continuous Thermodilution Measurements: Results of the EDIT-CMD Trial
Authors: Tijn Jansen, Annemiek de Vos, Regina Konst, Valeria Paradies, Angela Maas, Pieter Smits, Niels van Royen, Peter Damman
Journal: Journal of the American College of Cardiology (2022)
TCT-590 Comparison of Different Doses of Heparin on Prevention of Radial Artery Occlusion After Diagnostic Transradial Catheterization
Authors: Roberto Léo da Silva, Rodrigo Joaquim, Thaís da Silva, Pedro Beraldo, Vanderlei Pereira, Ricardo Zanella, Amanda Sousa, Fausto Feres, Jose Costa
Journal: Journal of the American College of Cardiology (2022)
Council on Foods and Nutrition
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study
Authors: Alexandre Bazinet, Faezeh Darbaniyan, Elias Jabbour, Guillermo Montalban-Bravo, Maro Ohanian, Kelly Chien, Tapan Kadia, Koichi Takahashi, Lucia Masarova, Nicholas Short, Yesid Alvarado, Musa Yilmaz, Farhad Ravandi, Michael Andreeff, Rashmi Kanagal-Shamanna, Irene Ganan-Gomez, Simona Colla, Wei Qiao, Xuelin Huang, Deborah McCue, Bailey Mirabella, Hagop Kantarjian, Guillermo Garcia-Manero
Journal: The Lancet Haematology (2022)
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial
Authors: Fred Saad, Antoine Thiery-Vuillemin, Pawel Wiechno, Boris Alekseev, Nuria Sala, Robert Jones, Ivo Kocak, Vincenzo Emanuele Chiuri, Jacek Jassem, Aude Fléchon, Charles Redfern, Jinyu Kang, Joseph Burgents, Christopher Gresty, Arnold Degboe, Noel W Clarke
Journal: The Lancet Oncology (2022)
Jaktinib (<scp>JAK1</scp>/2 inhibitor): A momelotinib derivative with similar activity and optimized dosing schedule
Authors: Ayalew Tefferi, Naseema Gangat, Animesh Pardanani
Journal: American Journal of Hematology (2022)

The authors declare no potential conflict of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis
Authors: Dan Wang, Bochuan Deng, Lu Cheng, Jieru Li, Jiao Zhang, Xiang Zhang, Xiaomin Guo, Tiantian Yan, Xin Yue, Yingying An, Bangzhi Zhang, Wenle Yang, Junqiu Xie, Rui Wang
Journal: Acta Pharmaceutica Sinica B (2022)

Pulmonary fibrosis (PF) is a pathological change caused by repeated injuries and repair dysfunction of the alveolar epithelium. Our previous study revealed that the residues Asn3 and Asn4 of peptide DR8 (DHNNPQIR-NH2) could be modified to improve stability and antifibrotic activity, and the unnatural hydrophobic amino acids α-(4-pentenyl)-Ala and d-Ala were considered in this study. DR3penA (DHα-(4-pentenyl)-ANPQIR-NH2) was verified to have a longer half-life in serum and to significantly inhibit oxidative damage, epithelial-mesenchymal transition (EMT) and fibrogenesis in vitro and in vivo. Moreover, DR3penA has a dosage advantage over pirfenidone through the conversion of drug bioavailability under different routes of administration. A mechanistic study revealed that DR3penA increased the expression of aquaporin 5 (AQP5) by inhibiting the upregulation of miR-23b-5p and the mitogen-activated protein kinase (MAPK) pathway, indicating that DR3penA may alleviate PF by regulating MAPK/miR-23b-5p/AQP5. Safety evaluation showed that DR3penA is a peptide drug without obvious toxicity or acute side effects and has significantly improved safety compared to DR8. Thus, our findings suggest that DR3penA, as a novel and low-toxic peptide, has the potential to be a leading compound for PF therapy, which provides a foundation for the development of peptide drugs for fibrosis-related diseases.
The forgotten survivor: A comprehensive review on <scp>Non‐Hodgkin</scp> lymphoma survivorship
Authors: Mohamad S. Alabdaljabar, Urshila Durani, Carrie A. Thompson, Louis S. Constine, Shahrukh K. Hashmi
Journal: American Journal of Hematology (2022)

The number of non-Hodgkin lymphoma (NHL) survivors is increasing. With the advancement of NHL therapies, it is crucial to focus on the challenges these survivors may face. Three main categories are to be considered in NHL survivorship, including quality of life and uncertainty about the future, possible physical health complications (including cardiovascular disease, infertility, and subsequent neoplasms), and the impact of novel NHL treatments and their potential complications. The latter includes CAR T-cell therapy, monoclonal antibodies, checkpoint inhibitors, and hematopoietic stem cell transplantation. In this report, we aim to shed the light on these aspects and to discuss survivorship care plan for NHL.